Pharmaceuticals, Biotechnology and Life Sciences
NOXXON said Wednesday it has enrolled the first patient in phase 1/2 trial in a therapy of increasing doses of…
Credence got a grant from the Bill & Melinda Gates Foundation with which it plans funding will support development of…
Ipsen and Blueprint medicines have entered a deal which expands Ipsen’s rare diseases portfolio to include BLU-782, a highly selective…
Sun pharma has launched the first and only FDA-approved sprinkle formulation of delayed-release duloxetine capsules, which is, as the company…
Aura Biosciences said in a presentation at American Academy od Ophtalmology that its lead product candidate light-activated AU-011 has the potential to be the first FDA approved therapy for the primary treatment of choroidal melanoma.
Gilead Sciences has appointed Andrew Dickinson, who currently serves as the company’s Executive Vice President, Corporate Development and Strategy, as Chief Financial Officer (CFO), effective November 1, while remaining a member of the senior leadership team, reporting to Daniel O’Day, Chairman and Chief Executive Officer.
COMPANY EXPANDS INTO NEW INDUSTRY SECTOR CHEYENNE, Wyo.–(BUSINESS WIRE)–MedX Holdings, Inc. (OTC Pink: MEDH) (the Company) is pleased to announce…
LOS ANGELES & RALEIGH, N.C.–(BUSINESS WIRE)–#biotech—Gemelli Biotech, producers of the ibs-smart™ blood test for irritable bowel syndrome with a diarrheal…
MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S.…
FARMINGTON, Conn.–(BUSINESS WIRE)–Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that…